Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Motor Neuron Disease
100%
Meta-analysis
100%
Systematic Meta-analysis
100%
Amyotrophic Lateral Sclerosis
100%
Clinical Trials
69%
Multi-arm
55%
Randomized Trial
55%
Adaptive Platform
50%
Expert Consensus
50%
Drug Repurposing
50%
Multi-arm multi-stage
50%
Mitochondrial Dysfunction
50%
Parkinson's Disease Model
50%
Evidence-based Approach
50%
Neuroprotective
50%
Randomized Placebo-controlled Trial
50%
Dopamine Agonist
50%
Confidence Interval
37%
Neurobehavior
25%
Trazodone
19%
Memantine
19%
Parkinson's Disease
18%
Neurodegenerative Diseases
17%
PubMed
17%
Trial Design
17%
Adaptive Platform Trial
15%
Amyotrophic Lateral Sclerosis Functional Rating Scale-revised
14%
Targeting Mitochondria
14%
Intervention Targets
14%
Drug Efficacy
12%
Stratified Meta-analysis
12%
Outcome Assessment
12%
Pre-clinical and Clinical Trials
12%
Low Prevalence
12%
Standardized Mean Difference
12%
Sources of Bias
12%
Individual Intervention
12%
Online Database
12%
Disabling Conditions
12%
Clinical Drug Trials
10%
Trial Registries
10%
Disease Biology
10%
Efficiency Gain
10%
Trial Participation
10%
Single-arm Trial
10%
Fixed Design
10%
Rapidly Progressive
10%
Innovative Trial Design
10%
Disease-modifying Therapy
10%
Novel Trial Designs
7%
Medicine and Dentistry
Motor Neuron Disease
100%
Arm
61%
Systematic Review
50%
Neuroprotective Agent
50%
Placebo
50%
Clinical Trial
22%
Trazodone
16%
Memantine
16%
Degenerative Disease
11%
Amyotrophic Lateral Sclerosis
11%
Rating Scale
11%
Riluzole
5%
Huntington's Disease
5%
Efficacy Study
5%
Alzheimer's Disease
5%
Clinical Study
5%
Multiple Sclerosis
5%
Decision Making
5%
Phenotypic Screening
5%
Parkinson's Disease
5%
Drug Induced Disease
5%
Health Care Cost
5%
Diseases
5%
Induced Pluripotent Stem Cell
5%
